MedPath

A study to Compare the use of pigment producing[Melanin] Cell Suspension[taken from the skin] With Skin Grafting On Adequate Re-pigmentation Of white patches seen post burns

Completed
Conditions
Other specified disorders of pigmentation,
Registration Number
CTRI/2019/04/018804
Lead Sponsor
JIPMER
Brief Summary

The purpose of this study is to identify the efficacy of autologous non cultured melanocyte keratinocyte cell suspension in relation to the standard care of split skin grafting in patients with post burn leucoderma patches **Research Hypothesis:** Autologous non-cultured melanocyte keratinocyte cell suspension is more effective in producing adequate re-pigmentation than split skin grafting in post burn leukoderma at 3 months

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
130
Inclusion Criteria

All patient with post burn leukoderma who attend the JIPMER plastic surgery outpatient department Age more than 12 years.

Exclusion Criteria

i.Any previous surgical treatments for post burn leukoderma in the past 1 year ii.Patients with ulcers over the hypopigmented patches iii.Patients with keloid tendency iv.Patients with autoimmune diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Repigmentation3 months
Graded based on the percentage of repigmentation of the treated areas as follow3 months
Excellent - 90-100% pigmentation,3 months
Good - 50-89%,3 months
Fair - 20-49%3 months
Poor - 0-20%3 months
Secondary Outcome Measures
NameTimeMethod
Patient satisfaction3months

Trial Locations

Locations (1)

Department of Plastic Surgery, Superspeciality Block, JIPMER

🇮🇳

Pondicherry, PONDICHERRY, India

Department of Plastic Surgery, Superspeciality Block, JIPMER
🇮🇳Pondicherry, PONDICHERRY, India
Dr Likhitha Reddy
Principal investigator
09581241574
drlikhithareddy@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.